BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34436612)

  • 21. Human papillomavirus vaccination and all-cause morbidity in adolescent girls: a cohort study of absence from school due to illness.
    Hviid A; Thorsen NM; Thomsen LN; Møller FT; Wiwe A; Frisch M; Valentiner-Branth P; Rytter D; Mølbak K
    Int J Epidemiol; 2021 May; 50(2):518-526. PubMed ID: 33547468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study.
    Krogsgaard LW; Vestergaard CH; Plana-Ripoll O; Lützen TH; Vestergaard M; Fenger-Grøn M; Bech BH; Rytter D
    PLoS One; 2017; 12(9):e0184658. PubMed ID: 28886180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study.
    Krogsgaard LW; Bech BH; Plana-Ripoll O; Thomsen RW; Rytter D
    Vaccine; 2019 Mar; 37(13):1763-1768. PubMed ID: 30803841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccination and primary ovarian insufficiency: an association based on ideology rather than evidence.
    Hawkes D; Buttery JP
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):70-2. PubMed ID: 26642064
    [No Abstract]   [Full Text] [Related]  

  • 25. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
    Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
    J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
    Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of subgroups in the Danish population for targeted human papillomavirus vaccination efforts.
    Voss SS; Nørgaard SK; Valentiner-Branth P
    Vaccine; 2023 May; 41(23):3525-3533. PubMed ID: 37142460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
    Schurink-Van't Klooster TM; Kemmeren JM; van der Maas NAT; van de Putte EM; Ter Wolbeek M; Nijhof SL; Vanrolleghem AM; van Vliet JA; Sturkenboom M; de Melker HE
    Vaccine; 2018 Oct; 36(45):6796-6802. PubMed ID: 30262246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-Dose Human Papillomavirus Vaccination and the Risk of Genital Warts: A Danish Nationwide Population-based Study.
    Baandrup L; Dehlendorff C; Kjaer SK
    Clin Infect Dis; 2021 Nov; 73(9):e3220-e3226. PubMed ID: 33048118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Human Papillomavirus Vaccination School-Entry Requirements and Vaccination Initiation.
    Ko JS; Goldbeck CS; Baughan EB; Klausner JD
    JAMA Pediatr; 2020 Sep; 174(9):861-867. PubMed ID: 32597928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018.
    Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE
    J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Batmunkh T; Dalmau MT; Munkhsaikhan ME; Khorolsuren T; Namjil N; Surenjav U; Toh ZQ; Licciardi PV; Russell FM; Garland SM; Mulholland K; von Mollendorf C
    Vaccine; 2020 Jun; 38(27):4316-4324. PubMed ID: 32387009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation.
    Restivo V; Costantino C; Fazio TF; Casuccio N; D'Angelo C; Vitale F; Casuccio A
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in Japan.
    Ozawa K; Hineno A; Kinoshita T; Ishihara S; Ikeda SI
    Drug Saf; 2017 Dec; 40(12):1219-1229. PubMed ID: 28744844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus immunization uptake among girls with a refugee background compared with Danish-born girls: a national register-based cohort study.
    Møller SP; Kristiansen M; Norredam M
    Eur J Cancer Prev; 2018 Jan; 27(1):42-45. PubMed ID: 27307374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.
    Donken R; Tami A; Knol MJ; Lubbers K; van der Sande MAB; Nijman HW; Daemen T; Weijmar Schultz WCM; de Melker HE
    BMC Public Health; 2018 Jul; 18(1):837. PubMed ID: 29976170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism.
    Frisch M; Besson A; Clemmensen KKB; Valentiner-Branth P; Mølbak K; Hviid A
    Int J Epidemiol; 2018 Apr; 47(2):634-641. PubMed ID: 29425361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.
    Grönlund O; Herweijer E; Sundström K; Arnheim-Dahlström L
    J Intern Med; 2016 Dec; 280(6):618-626. PubMed ID: 27478093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.
    Blomberg M; Dehlendorff C; Munk C; Kjaer SK
    Clin Infect Dis; 2013 Oct; 57(7):929-34. PubMed ID: 23804192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.